Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a

Status Recruiting

Clinical Trial Summary

Study of the ventricular activation patterns during left bundle area pacing and compare it with baseline activation during normal sinus rhythm in patients with and without baseline bundle branch conduction disorder.

Clinical Trial Description

Right ventricular (RV) pacing has long been the gold standard treatment for symptomatic brady arrhythmias. Right ventricular apical pacing has shown to cause electrical and mechanical desynchrony resulting in left ventricular (LV) dysfunction, and, in some cases, clinical heart failure together with other mechanical and arrhythmic complications. Hence, it was necessary to find a more physiologic method of pacing that ensures synchrony. His bundle pacing was first described in 2000, and is more recently adapted as a pacing method with less deleterious effects on the RV. However, lead dislodgement, high pacing thresholds, battery depletion, and difficulty identifying the exact location of His bundle were the most significant concerns related to this method. Subsequently, left bundle branch area pacing (LBB-AP), first described in 2017 by Huang et al, has emerged as safe alternative with excellent lead stability and capture threshold, and more ability to correct distal conduction disease as compared to His bundle pacing. Recent studies report promising mid-term outcome concerning left ventricular desynchrony. To the best of our knowledge, bi-ventricular activation was never studied in patients with LBB-AP. Multiple tools have been used to assess biventricular (BiV) synchrony specially with chronic resynchronization therapy (CRT) including echocardiography and 12 lead ECG. Eschalier et al. found that epicardial noninvasive ECG mapping, was better at predicting clinical CRT response than QRS duration or the presence of LBBB. Activation patterns and timings with RV apical pacing, native LBBB, and BiV pacing have been well studied using this tool. With LBBP, however, these activation parameters have not yet been described. This study aims to evaluate bi-ventricular activation in patients equipped with LBB-AP using non-invasive 3D mapping system in patients with or without baseline ventricular conduction disorder. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05401851
Study type	Interventional
Source	Universitair Ziekenhuis Brussel
Contact	Carlo de Asmundis, MD, PhD
Phone	+32024763704
Email	HRMC@uzbrussel.be
Status	Recruiting
Phase	N/A
Start date	March 24, 2022
Completion date	October 21, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00976482` - Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications	N/A
Completed	`NCT01089634` - Left Ventricular Capture Management Study
Completed	`NCT02930980` - Micra Accelerometer Sensor Study 2	N/A
Recruiting	`NCT03693157` - The Safety and Efficacy of FFR Protocol in NTUH System
Completed	`NCT05357716` - Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
Recruiting	`NCT05585411` - PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial	N/A
Completed	`NCT01522755` - Predictive Factors of a Successful Implant of the CapsureFix MRI Model 5086
Completed	`NCT01513538` - Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function	N/A
Completed	`NCT05997004` - Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT04905199` - Temporary Transvenous Pacemaker Placement by Intracavitary Electrocardiogram Monitoring
Not yet recruiting	`NCT04437901` - COVIDAR - Arrhythmias in COVID-19
Terminated	`NCT01535404` - Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function Study	N/A
Completed	`NCT01523704` - Safety and Efficacy Study of IPG Patient With Home Monitoring	N/A
Recruiting	`NCT06324682` - ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Completed	`NCT01715558` - Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2	N/A
Recruiting	`NCT01310907` - Identify the Genes Polymorphisms Related to Non-familial Bradyarrhythmia	N/A
Recruiting	`NCT04697797` - Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing
Recruiting	`NCT04831125` - Conduction System Pacing International Registry (CONSPIRE)
Completed	`NCT01897558` - Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a Comparison Study — LBBAP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms